288 related articles for article (PubMed ID: 29556944)
1. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
Yoo J; Kim BS; Yoon HJ
Ann Nucl Med; 2018 Jun; 32(5):328-336. PubMed ID: 29556944
[TBL] [Abstract][Full Text] [Related]
2. MRI versus breast-specific gamma imaging (BSGI) in newly diagnosed ductal cell carcinoma-in-situ: a prospective head-to-head trial.
Keto JL; Kirstein L; Sanchez DP; Fulop T; McPartland L; Cohen I; Boolbol SK
Ann Surg Oncol; 2012 Jan; 19(1):249-52. PubMed ID: 21739318
[TBL] [Abstract][Full Text] [Related]
3. Retrospective and comparative analysis of (99m)Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women.
Yu X; Hu G; Zhang Z; Qiu F; Shao X; Wang X; Zhan H; Chen Y; Deng Y; Huang J
BMC Cancer; 2016 Jul; 16():450. PubMed ID: 27401536
[TBL] [Abstract][Full Text] [Related]
4. Comparison of
Liu H; Zhan H; Sun D
BMC Cancer; 2020 May; 20(1):463. PubMed ID: 32448217
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Kim JS; Lee SM; Cha ES
Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
[TBL] [Abstract][Full Text] [Related]
6. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study.
Brem RF; Fishman M; Rapelyea JA
Acad Radiol; 2007 Aug; 14(8):945-50. PubMed ID: 17659240
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
[TBL] [Abstract][Full Text] [Related]
9. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.
Brem RF; Floerke AC; Rapelyea JA; Teal C; Kelly T; Mathur V
Radiology; 2008 Jun; 247(3):651-7. PubMed ID: 18487533
[TBL] [Abstract][Full Text] [Related]
10. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast.
Lee SK; Yang JH; Woo SY; Lee JE; Nam SJ
Br J Surg; 2013 Dec; 100(13):1756-63. PubMed ID: 24227361
[TBL] [Abstract][Full Text] [Related]
11. Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.
Si J; Guo R; Huang N; Xiu B; Zhang Q; Chi W; Wu J
Cancer Med; 2019 Dec; 8(18):7586-7593. PubMed ID: 31660702
[TBL] [Abstract][Full Text] [Related]
12. Breast-specific gamma imaging or ultrasonography as adjunct imaging diagnostics in women with mammographically dense breasts.
Zhang Z; Wang W; Wang X; Yu X; Zhu Y; Zhan H; Chen Z; Li B; Huang J
Eur Radiol; 2020 Nov; 30(11):6062-6071. PubMed ID: 32524221
[TBL] [Abstract][Full Text] [Related]
13. A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Kondo T; Hayashi N; Ohde S; Suzuki K; Yoshida A; Yagata H; Niikura N; Iwamoto T; Kida K; Murai M; Takahashi Y; Tsunoda H; Nakamura S; Yamauchi H
J Surg Oncol; 2015 Oct; 112(5):476-80. PubMed ID: 26346047
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral metabolic heterogeneity predicts invasive components in breast ductal carcinoma in situ.
Yoon HJ; Kim Y; Kim BS
Eur Radiol; 2015 Dec; 25(12):3648-58. PubMed ID: 26063655
[TBL] [Abstract][Full Text] [Related]
15. High rate of postoperative upstaging of ductal carcinoma in situ when prioritizing ultrasound evaluation of mammography-detected lesions: a single-center retrospective cohort study.
Hsieh YC; Lo C; Lee YH; Chien N; Lu TP; Tsai LW; Wang MY; Kuo WH; Chang YC; Huang CS
World J Surg Oncol; 2023 Feb; 21(1):48. PubMed ID: 36804000
[TBL] [Abstract][Full Text] [Related]
16. Histologic factors predicting invasion in patients with ductal carcinoma in situ (DCIS) in the preoperative core biopsy.
Al Nemer AM
Pathol Res Pract; 2017 May; 213(5):429-434. PubMed ID: 28285968
[TBL] [Abstract][Full Text] [Related]
17. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
[TBL] [Abstract][Full Text] [Related]
18. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
[TBL] [Abstract][Full Text] [Related]
19. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
[TBL] [Abstract][Full Text] [Related]
20. Lesion Size on Ultrasonography Predicts Potential Invasion in Ductal Carcinoma in situ Preoperatively Diagnosed by Breast Needle Biopsy.
Shimoyama K; Osako T; Mitsuhashi T; Akiyama F; Iwase T
Acta Med Okayama; 2017 Jun; 71(3):233-240. PubMed ID: 28655943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]